Show off clearer skin
and less itch

DUPIXENT was studied in 3 clinical trials with more than 2,100 adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).

 

DUPIXENT results
in adults

In two clinical trials at 16 weeks (DUPIXENT vs placebo):

~4X
SAW CLEAR OR
ALMOST CLEAR SKIN

37% on DUPIXENT vs
9% not on DUPIXENT

>3X
HAD SIGNIFICANT
ITCH REDUCTION

38% on DUPIXENT vs
11% not on DUPIXENT

Almost half of adults saw

≥75%
Clearer
skin

48% on DUPIXENT vs 13% not on DUPIXENT

Many saw

≥90%
Clearer
skin

33% on DUPIXENT vs 7% not on DUPIXENT

view BEFORE AND AFTER
photos WITH DUPIXENT

Click and drag
to see results
Click and drag
to see results

Real patients shown. Additional factors (including possible use of other treatments) may have impacted results. Individual results may vary.

Have you spoken to a dermatologist or allergist about DUPIXENT?

Go back

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program services and get one-on-one support every step of the way, including help with filling your first prescription.

Enroll in DUPIXENT MyWay

If you're still struggling with moderate-to-severe eczema, maybe it's time to change the conversation.

WATCH A VIDEO ON ASKING
ABOUT DUPIXENT

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.

Get Started

Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.

Find a Specialist Near Me

SHOW OFF WHAT’S POSSIBLE IN THE LONG RUN

Long-term results from a clinical trial that studied DUPIXENT for 52 weeks (DUPIXENT + topical corticosteroids [TCS] vs TCS only):

Clear or almost
clear skin at
16 weeks
39% on DUPIXENT + TCS
vs 12% using TCS only

Long-lasting
clearer skin at
16 and 52 weeks
22% on DUPIXENT + TCS
vs 7% using TCS only

Fast itch relief as
soon as 2 weeks
18% on DUPIXENT + TCS
vs 8% using TCS only

Itch relief that
lasts at 52 weeks
51% on DUPIXENT + TCS vs
13% using TCS only

DEMONSTRATED LONG-
TERM SAFETY PROFILE

Long-term safety results for adults continuing on DUPIXENT in an extension study through 5 years were consistent with those seen in the original clinical trials.

MOST COMMON SIDE
EFFECTS INCLUDE:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT

What You Should Know About the Adult Patients in THESE Studies:

52%
Had moderate
atopic dermatitis
48%
Had severe
atopic dermatitis
~38 years
Average age
~28 years
Average duration

of the disease
~55%
Average body
surface
area
involvement
DID YOU KNOW?
DUPIXENT isn’t a
daily medication

HEAR FROM
REAL PATIENTS

I’ve been struggling with eczema since college. For years, I was super itchy and I felt like my eczema was often on my mind. Things like going to the pool or being out in the heat could irritate my skin so much, I’d try to avoid it … I’m happy to have found a treatment that works for me. If you’re struggling with moderate-to-severe eczema, know that there’s hope. It is possible for your skin to feel more comfortable.

DIANA TAURASI,

All-star basketball athlete and real DUPIXENT patient living
with moderate-to-severe eczema. Individual results may vary.

Hear from more patients